Oura IPO Closing Market Cap: What Does the Market Price?

Oura’s anticipated public offering has become one of the more contested valuation questions in prediction markets heading into late 2026. The $17.5 billion to $20 billion band holds a 24% implied probability on Polymarket as of June 1, 2026, but that figure masks a dramatic single-day repricing that cut contract value by more than a quarter. The data tells a clear story: market participants are revising their assumptions about where Oura lands at IPO close, and the distribution of outcomes has widened considerably.

The market question asks which valuation band Oura’s IPO closing market cap will fall into before January 1, 2027. The YES contract for the $17.5B to $20B band trades at $0.24, while the NO contract trades at $0.76. Total volume stands at $2,050, with all of that volume recorded in the past 24 hours. The market resolves on January 1, 2027.

How the Oura IPO Valuation Contract Works

This contract resolves YES if Oura’s closing market capitalization on its first trading day falls between $17.5 billion and $20 billion, inclusive. Resolution depends on the official closing price and share count at IPO. If Oura does not complete a public offering before January 1, 2027, a separate outcome band labeled ‘No IPO before January 2027’ resolves instead.

• YES ($0.24): Oura closes its IPO with a market cap between $17.5 billion and $20 billion.
• NO ($0.76): Oura closes at any other valuation, including below $17.5 billion, above $20 billion, or does not IPO before the resolution date.

A NO outcome covers a wide range of scenarios. Oura could price aggressively above $20 billion, reflecting strong institutional demand for health wearable platforms. Alternatively, a risk-off IPO window could push pricing into the $12.5B to $15B or $15B to $17.5B bands, both of which trade as separate contracts. The ‘No IPO before January 2027’ outcome remains a live possibility given how frequently anticipated offerings slip past target windows.

Sponsored Partner

Market Signals: A Sharp Repricing and Thin Liquidity

The momentum composite for this contract is unambiguously bearish. The 1-hour change registers at 0.0%, but the 24-hour change shows a decline of 25.5%, with a trend score of 36.36 out of 100. That combination, a flat near-term print against a steep daily loss with a below-midpoint trend score, signals that selling pressure was concentrated and has not yet stabilized. The most likely catalyst is a reassessment of the IPO timeline or a broader repricing of private tech valuations following macro developments in late May and early June 2026.

Total volume for this contract is $2,050, with all volume recorded in the past 24 hours. Liquidity stands at $18,904 in the order book. By any standard threshold, this market is extremely thin. The historical base rate suggests that low-volume prediction markets carry elevated noise relative to signal, and single large trades can move prices materially. The 25.5% single-day decline likely reflects one or a small number of trades rather than a broad reassessment by many independent participants.

• The $2,050 total volume flags this market as LOW confidence. Price movements may not reflect consensus views.
• The 24-hour price change of -25.5% is the dominant signal, not gradual drift.
• A trend score of 36.36 confirms the market is in a declining posture, not a consolidation phase.
• The 1-hour flatness after a steep 24-hour drop may indicate the initial selling has cleared, but does not confirm a floor.
• Liquidity of $18,904 means new entrants can move price meaningfully with modest capital.

Lines Analysis: Oura Valuation and the IPO Probability Distribution

Within the confidence interval that a 24% implied probability represents, the $17.5B to $20B band is plausible but not favored. Oura, the Finnish smart ring company, was last reported at a private valuation near $5.2 billion in its 2023 Series D funding round. For a closing IPO market cap of $17.5B to $20B to materialize, Oura would need to price at roughly 3.4 to 3.8 times its last known private valuation. That kind of step-up is not unprecedented in consumer health technology, particularly for platforms with strong recurring revenue from subscription services. However, the IPO window in 2026 has been selective, and institutional appetite for hardware-plus-subscription models has been mixed following high-profile public market disappointments in adjacent categories.

The alternative scenario, where this contract resolves NO, does not require Oura to fail. A NO outcome is equally consistent with Oura pricing above $20 billion, which would reflect exceptional demand, or with a delay past the January 1, 2027 resolution date. The $20B+ band and the ‘No IPO before January 2027’ outcome both represent plausible paths for the 76% NO probability. A softer-than-expected IPO market in the second half of 2026, driven by Federal Reserve policy uncertainty or a widening of credit spreads, could push Oura’s bankers to target a more conservative valuation band or delay entirely.

• Oura’s subscription revenue model (Oura Ring membership) supports recurring revenue multiples, which favor higher valuation bands if growth metrics hold.
• The Federal Reserve’s rate posture through mid-2026 affects the discount rates applied to growth-stage IPO candidates, directly influencing achievable valuation bands.
• A ‘No IPO before January 2027’ resolution would collapse probability across all valuation band contracts and concentrate value in that single outcome.
• Comparable wearable health IPOs in 2024 and 2025 priced below pre-IPO secondary market expectations in most cases, establishing a cautionary base rate.
• Any update to Oura’s S-1 filing or roadshow schedule would be the single highest-impact catalyst before the resolution date.

Total volume of $2,050 limits the analytical weight this market can carry. The data favors NO at 76%, but the specific distribution between ‘Oura prices above $20B,’ ‘Oura prices in a lower band,’ and ‘Oura does not IPO’ is not resolvable from this contract alone. Traders watching this market should weight the thin liquidity heavily when interpreting price as signal.

LINES VERDICT

NO: Outside the Target Band

The $17.5B to $20B band is a specific and narrow target for a company that has not yet filed publicly, and the market has priced the probability of hitting that precise range at less than one in four. The historical base rate for IPO valuations landing within a pre-specified 12.5% band is low, and the current macro environment adds further dispersion to outcomes.

What the market says: A 24% implied probability reflects genuine uncertainty, not consensus. With a thin $2,050 total volume and a resolution date of January 1, 2027, this market will remain volatile as any Oura IPO news emerges.

Economic and Market Context

The Federal Reserve’s rate posture in 2026 remains a central variable for IPO market conditions. The related market ‘How many Fed rate cuts in 2026?’ prices at 69% for at least one cut, which, if realized, would improve the discount rate environment for growth-stage IPO candidates like Oura in the second half of 2026. A more accommodative Fed tends to expand the range of achievable IPO valuations, which could shift probability mass toward the $20B+ band rather than the $17.5B to $20B band. The related IPO market pricing at 100% for ‘IPOs before 2027’ suggests the broader market strongly expects some major IPOs to close this year, though this does not directly confirm Oura’s timeline.

Before January 1, 2027, the events most likely to move this contract are: an Oura S-1 SEC filing, a roadshow announcement with an indicative price range, any Federal Reserve communication that materially shifts the growth equity discount rate, and broader risk sentiment shifts in the consumer technology sector. Each of these events carries the potential to reprice the $17.5B to $20B band by 10 or more percentage points in a single session.

What does a 24% implied probability mean for this market?

A 24% implied probability means the market assigns roughly one-in-four odds that Oura’s IPO closing market cap lands between $17.5 billion and $20 billion. It does not mean the outcome is unlikely to occur, only that other outcomes are collectively more probable.

What does the NO contract represent?

Holding the NO contract pays out if Oura’s closing market cap falls outside the $17.5B to $20B range, including if Oura prices higher, prices in a different band, or does not complete an IPO before January 1, 2027.

What data releases or events move this contract’s price?

An Oura S-1 filing, roadshow pricing guidance, Federal Reserve rate decisions affecting growth equity valuations, and broader IPO market conditions in the second half of 2026 are the primary catalysts for price movement.

When and how does this market resolve?

The market resolves on January 1, 2027, based on the official closing market capitalization of Oura’s IPO. If no IPO occurs before that date, the ‘No IPO before January 2027’ outcome resolves instead of any valuation band.

How reliable is the volume and liquidity data for this market?

Total volume of $2,050 and order book liquidity of $18,904 classify this market as LOW confidence. Price movements in thin markets can reflect single large trades rather than broad participant consensus, limiting the signal value of current pricing.